Abraham Cornelis Lardée

Title: Abraham Cornelis Lardée: Innovator in Pharmaceutical Tablets

Introduction

Abraham Cornelis Lardée is a notable inventor based in Echt, Netherlands, recognized for his contribution to the pharmaceutical industry. He holds one patent that enhances the formulation of dispersible tablets, particularly those used in delivering essential medications.

Latest Patents

Lardée's significant patent is titled "Tablet comprising crospovidone." This invention relates to a dispersible tablet that includes crospovidone and a β-lactam antibiotic, such as amoxicillin. The patent covers not only the tablet itself but also the method of preparing it and its applications in medicine. His work aims to improve the efficiency and effectiveness of drug delivery systems.

Career Highlights

Currently, Abraham Cornelis Lardée is employed at DSM Sinochem Pharmaceuticals Netherlands B.V. In his role, he contributes to innovation and research within the pharmaceutical sector, aligning with the company’s commitment to advancing healthcare solutions through scientific discovery.

Collaborations

Throughout his career, Lardée has worked closely with various teams at DSM Sinochem Pharmaceuticals, collaborating with fellow researchers and scientists to bring new and improved products to market. His efforts are pivotal in supporting the company’s dedication to providing high-quality pharmaceutical formulations.

Conclusion

Abraham Cornelis Lardée exemplifies the spirit of innovation in the pharmaceutical industry. His patent on dispersible tablets featuring crospovidone represents a significant advancement in medication delivery. As he continues to work with DSM Sinochem Pharmaceuticals, Lardée’s contributions reflect the ongoing commitment to enhancing health outcomes through innovative solutions.